Amperometric sensor and method for its manufacturing

• US 9,700,252 B2
• Filed: 08/02/2013
• Issued: 07/11/2017
• Est. Priority Date: 06/19/2006
• Status: Active Grant

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Inventors: Staib, Arnulf, Jernigan, Walter, Mischler, Reinhold, Hajnsek, Martin, Buck, Harvey
• Primary Examiner(s): JANG, CHRISTIAN YONGKYUN
• Application Number:
  US13/958,404
• Publication Number:
  US 20150038814A1
• Time in Patent Office: 1,439 Days
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors

Abstract

An in vivo amperometric sensor is provided for measuring the concentration of an analyte in a body fluid. The sensor comprises a counter electrode and a working electrode, and the working electrode comprises a sensing layer which is generally water permeable and arranged on a support member adjacent to a contact pad. The sensing layer comprises an immobilized enzyme capable of acting catalytically in the presence of the analyte to cause an electrical signal. The sensing layer has an upper surface facing the body fluid and a lower surface facing away from the body fluid, and the immobilized enzyme is distributed within the sensing layer in such a way that the enzyme concentration in the middle between the upper and lower surfaces is at least as high as on the upper surface of the sensing layer.

Claims

1. An in vivo amperometric biosensor for implantation into a human or animal to generate a signal corresponding to analyte concentration in a body fluid of the human or animal, the biosensor comprising:

a support member;

working and counter electrodes arranged on the support member; and

a sensing layer with immobilized enzyme distributed therein, the sensing layer at least partially covering the working electrode;

wherein, the sensing layer has an effective diffusion coefficient such that, when the biosensor is implanted for use, diffusion of the analyte in the sensing layer is the rate-limiting step in generating the signal corresponding to analyte concentration.

2. The biosensor of claim 1, wherein the sensing layer has an effective diffusion coefficient D_eff of analyte through the sensing layer of about 10-times to about 1000-times lower than the coefficient D of the analyte in water.

3. The biosensor of claim 1, further comprising a diffusion barrier located above the sensing layer, wherein the diffusion barrier inhibits diffusion of analyte into the sensor to the extent that analyte concentration at the upper surface of the sensing layer is at most ten times lower than in the body fluid surrounding the implanted sensor.

4. The biosensor of claim 1, wherein the enzyme comprises a cross-linked enzyme forming a complex with a hydrophilic partner.

5. The biosensor of claim 4, wherein the cross-linked enzyme has an average chain length of three to ten enzyme molecules.

6. The biosensor of claim 1, wherein the sensing layer has a thickness of between 5 μ

m and 100 μ

m.

7. The biosensor of claim 1, wherein the sensing layer has a thickness of between 20 μ

m and 70 μ

m.

8. The biosensor of claim 1, wherein, when the biosensor is implanted for use, the sensing layer has an upper surface facing the body fluid and facing away from the support member and a lower surface facing away from the body fluid and facing toward the support member.

9. The biosensor of claim 1, wherein the sensing layer has an enzyme concentration in the middle of the sensing layer between the upper and lower surfaces of the sensing layer at least as high as on the upper surface of the sensing layer.